|
|
Original Manuscripts |
| Therapy |
| Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD) |
1861 |
| J Taguchi,
Y Miyazaki,
S Yoshida,
T Fukushima,
Y Moriuchi,
I Jinnai,
T Matsuo,
K Kuriyama & M Tomonaga
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
| BP1, a new homeobox gene, is frequently expressed in acute leukemias |
1867 |
| SB Haga,
S Fu,
JE Karp,
DD Ross,
DM Williams,
WD Hankins,
F Behm,
FW Ruscetti,
M Chang,
BD Smith,
D Becton,
SC Raimondi & PE Berg
|
|
Abstract
Full Article (PDF)
|
|
| Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice |
1876 |
| D Louz,
M van den Broek,
S Verbakel,
Y Vankan,
K van Lom,
M Joosten,
D Meijer,
B Löwenberg & R Delwel
|
|
Abstract
Full Article (PDF)
|
|
| MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study |
1885 |
| G Cuthbert,
K Thompson,
S McCullough,
A Watmore,
H Dickinson,
N Telford,
F Mugneret,
C Harrison,
M Griffiths & N Bown
|
|
Abstract
Full Article (PDF)
|
|
| Gene Fusion Proteins |
| Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins |
1892 |
| E Laurent,
M Talpaz,
M Wetzler & R Kurzrock
|
|
Abstract
Full Article (PDF)
|
|
| The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds |
1898 |
| C Caslini,
A Serna Alarcòn,
JL Hess,
R Tanaka,
KG Murti & A Biondi
|
|
Abstract
Full Article (PDF)
|
|
| Regulation of Translation in NB4 Cell Lines |
| Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2 |
1909 |
| A Grolleau,
J Wietzerbin & L Beretta
|
|
Abstract
Full Article (PDF)
|
|
| Sensitivity and Resistance to Therapy |
| Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells |
1915 |
| T Ando,
M Nishimura & Y Oka
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis and Raf Regulation |
| Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells |
1921 |
| C Weinstein-Oppenheimer,
LS Steelman,
PA Algate,
WL Blalock,
C Burrows,
PE Hoyle,
JT Lee,
PW Moye,
JG Shelton,
R Franklin & JA McCubrey
|
|
Abstract
Full Article (PDF)
|
|
| Minimal Residual Disease in Childhood ALL and Prognosis |
| Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group |
1939 |
| A Biondi,
MG Valsecchi,
T Seriu,
E D’Aniello,
MJ Willemse,
K Fasching,
A Pannunzio,
H Gadner,
M Schrappe,
WA Kamps,
CR Bartram,
JJM van Dongen & ER Panzer-Grümayer
|
|
Abstract
Full Article (PDF)
|
|
| Normal Hemopoiesis and Stemcellology |
| Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood |
1944 |
| N Kusadasi,
PL van Soest,
AE Mayen,
JLM Koevoet & RE Ploemacher
|
|
Abstract
Full Article (PDF)
|
|
| Stem Cell Transplantation and Myeloablation |
| A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation |
1954 |
| E Olavarria,
M Hassan,
A Eades,
C Nilsson,
A Timms,
J Matthews,
C Craddock,
E Kanfer,
J Apperley & J Goldman
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| De novo acute B cell leukemia/lymphoma with t(14;18) |
1960 |
| A Stamatoullas,
G Buchonnet,
S Lepretre,
P Lenain,
B Lenormand,
C Duval,
M-P Callat,
P Gaulard,
C Bastard & H Tilly
|
|
Abstract
Full Article (PDF)
|
|
| Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma |
1967 |
| J Kalla,
S Stilgenbauer,
C Schaffner,
S Wolf,
G Ott,
A Greiner,
A Rosenwald,
H Döhner,
HK Müller-Hermelink & P Lichter
|
|
Abstract
Full Article (PDF)
|
|
| Myeloma and Other Gammopathies |
| Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance |
1975 |
| R Königsberg,
J Ackermann,
H Kaufmann,
N Zojer,
E Urbauer,
E Krömer,
U Jäger,
H Gisslinger,
S Schreiber,
R Heinz,
H Ludwig,
H Huber & J Drach
|
|
Abstract
Full Article (PDF)
|
|
| Epidemiology |
| Trends in mortality from leukemia in subsequent age groups |
1980 |
| F Levi,
F Lucchini,
E Negri,
T Barbui & C La Vecchia
|
|
Abstract
Full Article (PDF)
|
|
| Bio-Technical Methods Section (BTS) |
| Identification of genes potentially involved in LMO2-induced leukemogenesis |
1986 |
| J Davenport,
GAM Neale & R Goorha
|
|
Abstract
Full Article (PDF)
|
|
Bio-Technical Methods Section (BTS) |
Quantitation of DNA topoisomerase II and  in human leukaemia cells by immunoblotting |
1997 |
| K Padget,
ADJ Pearson & CA Austin
|
|
Abstract
Full Article (PDF)
|
|
| Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes |
2006 |
| S Saußele,
A Weißer,
MC Müller,
M Emig,
P La Rosée,
P Paschka,
C Kuhn,
A Willer,
R Hehlmann & A Hochhaus
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML |
2011 |
| M Dupont,
E Jourdan & J Chiesa
|
|
Full Article (PDF)
|
|
| Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO) |
2013 |
| H Iwata,
M Kami,
Y Kishi,
Y Oki,
Y Tanaka,
K Takeuchi,
I Yamazaki,
R Suzuki,
S Morinaga & Y Mutou
|
|
Full Article (PDF)
|
|
| Loss of the TSG101 leucine zipper domain in aggressive non-Hodgkin’s lymphomas |
2014 |
| M Ferrer,
S Hernández,
E Campo & PA Lazo
|
|
Full Article (PDF)
|
|
